PBX3 divergent transcript (PBX3-DT)

PBX3-DT ("PBX3 divergent transcript") is referenced in some genetic databases and genomic studies as a transcript associated with the PBX3 locus, possibly representing a long non-coding RNA or an uncharacterized RNA species expressed divergently from the PBX3 gene. There is currently no direct evidence for its biological function, disease association, or therapeutic targeting. It is not considered a classic molecular target. The term PBX3-DT is inconsistently used in the literature, and its relevance as a drug discovery target is unclear. Most available data relates instead to the PBX3 protein, a TALE-class homeodomain transcription factor involved in development, oncogenic transformation, and transcriptional regulation in various contexts[2][3]. The divergent transcript itself is not characterized as a therapeutic target and lacks structured biological information[4]. The "PBX3 divergent transcript" is not a recognized molecular target by standard therapeutic or drug discovery databases. It has sparse and inconsistent characterization; not present in major biological, pharmaceutical, or disease-focused databases as a functional molecule[4]. The term is likely used in a purely genomic context (transcript annotation), not as a protein or biologically characterized target.

Other names

PBX3 divergent transcript (PBX3-DT)PBX3-DT (database abbreviation)

None described